GUTS
Fractyl Health, Inc.
$0.77
0.00 (0.00%) Today
0.03 (3.57%) Pre-market
— up— down
Open
$0.80
$0.80Previous Close
$0.80
$0.80Day Range
$0.75 – $0.80
$0.75 – $0.8052-Week Range
$0.38 – $2.45
$0.38 – $2.45Earnings Date
Aug 13, 2026
Aug 13, 2026Volume
528.42K
528.42KExchange
NasdaqGM
NasdaqGMAbout GUTS
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1 (GLP-1).
Related
News
U.S. crude oil hovers above $70 as Trump, Iran issue mixed messages on talks in Qatar
CNBC · 1h ago
Buffett delays annual donation to Gates Foundation pending review of Jeffrey Epstein ties: WSJ
CNBC · 3h ago
UK economy grows as expected before Iran war impact, ONS data shows - Reuters
Reuters · 5h ago
Oil set for steepest quarterly loss since 2020 as traders focus on US-Iran talks - Reuters
Reuters · 9h ago
Trump urges gasoline retailers to lower prices, warns of 'big problems' if they don't - Reuters
Reuters · 11h ago